Read More: eGenesis Announces World’s First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient

BACK TO LEADERSHIP

Anil Chandraker, M.D.

Clinical Advisor

Dr. Anil Chandraker is the Medical Director of Kidney and Pancreas Transplantation and the Director of the Transplantation Research Center at the Brigham and Women’s Hospital. He is an Associate Professor of Medicine at Harvard Medical School and has served as President of the American Society of Transplantation.

Dr. Chandraker has academic interests in basic, translational and clinical areas of transplantation research. He has served as a PI or Protocol Chair on several NIH sponsored Clinical Trials in Organ Transplantation. In addition he has clinical/translational research interests in BK nephropathy, antibody mediated rejection and generation of regulatory T cells. His basic research interest is focused primarily on T cell costimulatory pathways such as the B7-CD28/CTLA4 and PDL1-PD1 pathways and their role in tolerance and chronic allograft injury. He has mentored more than thirty fellows in basic and clinical research and received research funding from the NIH, Juvenile Diabetes Research Foundation and the National Kidney Foundation amongst others. He has co-authored over 200 original scientific articles, review articles and book chapters including contributing chapters to Harrisons, Brenner and Rectors The Kidney, AST Primer on Transplantation and ACP Medicine Textbook, amongst others. He has served on various grant review bodies for the NIH, Medical Research Council (UK), National Kidney Research Fund (UK) Canadian Institute of Health Research and the Harvard Catalyst.

Dr. Chandraker graduated from Glasgow University in 1987 and trained in clinical medicine in the United Kingdom before coming to the Brigham and Women’s Hospital/Harvard Medical School in 1995 to complete his Fellowship in Nephrology/Transplant Immunology.

Anil Chandraker